The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy

Mahsa Yaghobinejad; Federica Cavallo; Laura Conti; Elena Quaglino

doi:10.31083/j.fbl2712338

The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy

Front Biosci (Landmark Ed). 2022 Dec 29;27(12):338. doi: 10.31083/j.fbl2712338.

Authors

Mahsa Yaghobinejad¹, Federica Cavallo², Laura Conti², Elena Quaglino²

Affiliations

¹ Anatomy Department, Tehran University of Medical Sciences, 1417653761 Tehran, Iran.
² Molecular Biotechnology Center "Guido Tarone'', Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.

PMID: 36624956
DOI: 10.31083/j.fbl2712338

Abstract

The 21st international congress on Progress in Vaccination against Cancer (PIVAC-22, https://www.pivac22.it/) was held from September 26 to September 28, 2022, at the Molecular Biotechnology Center "Guido Tarone" in Turin, Italy. The meeting covered the most recent advances in the field of cancer immunotherapy, with a focus on the tumor microenvironment, and addressed how alterations to the microenvironment's molecular and metabolic features and the microbiota impact upon the response to immunotherapy.

Keywords: PIVAC-22; cancer vaccination; immune resistance; immunotherapy; microbiota; tumor microenvironment.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunotherapy
Italy
Neoplasms* / prevention & control
Tumor Microenvironment
Vaccination